Skip to content
LULULUW45W45W45

Drawing based on the label description. No photo yet.

“Amlodipine, valsartan and hydrochlorothiazide tablets USP, 10 mg/320 mg/25 mg are light brick red colored, capsule shaped, film coated, biconvex tablets, debossed with 'LU' on one side and 'W45' on the other side”

LU W45 pill

Pill with imprint LU W45 is red, capsule, 16 mm and has been identified as Amlodipine, Valsartan and Hydrochlorothiazide 10 mg / 320 mg / 25 mg. It is used for high blood pressure. It is supplied by Lupin Pharmaceuticals, Inc.

Amlodipine, Valsartan and Hydrochlorothiazide 10 mg / 320 mg / 25 mg

Imprint
LU W45
Strength
Amlodipine 10 mg / Valsartan 320 mg / Hydrochlorothiazide 25 mg
Used for
High blood pressure
Color
Red
Shape
Capsule / oblong
Size
16 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Lupin Pharmaceuticals, Inc
Drug class
Thiazide diuretic (water pill)
NDC
68180-775, 68180-775-09, 68180-775-06, 68180-775-02

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Amlodipine Valsartan and Hydrochlorothiazide pills and guides

What is Amlodipine Valsartan and Hydrochlorothiazide used for?

Amlodipine Valsartan and Hydrochlorothiazide is used for high blood pressure.

Medicine type
Thiazide diuretic (water pill)
Official uses from the US prescribing label

Exforge HCT (amlodipine, valsartan, and hydrochlorothiazide) is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including amlodipine, hydrochlorothiazide, and the angiotensin II receptor blocker (ARB) class to which valsartan principally belongs. There are no controlled trials demonstrating risk reduction with Exforge HCT.

Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).

Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.

Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (e.g., patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.

Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.

Limitations of Use

Exforge HCT is not indicated for the initial therapy of hypertension.

From the FDA-approved label on DailyMed (published Dec 15, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows LU and the other side shows W45.
  • It is red, capsule, 16 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Amlodipine Besylate, Valsartan, Hydrochlorothiazide

Inactive: Cellulose, Microcrystalline, Croscarmellose Sodium, Crospovidone (15 Mpa.s At 5%), Ferric Oxide Red, Hypromelloses, Magnesium Stearate, Polyethylene Glycol 400, Silicon Dioxide, Titanium Dioxide

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Amlodipine Valsartan and Hydrochlorothiazide pills